ASeq Newsletter β’ 36 implied HN points β’ 18 Jan 24
- Spatial revenue for 10X Genomics is increasing, while single cell revenue growth is slowing down.
- There may not be much growth expected in single cell applications for 10X Genomics, but spatial sequencing shows potential for growth.
- 10X Genomics faces competition in the single cell market, but may retain a significant market share.